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BOOK REVIEW:
REPRODUCTIVE TECHNOLOGIES AND THE LAW
Authored by: Judith Daar *
Reproductive Technologies and the Law explores the burgeoning
practice of assisted conception from the perspective of law, medicine,
public policy and ethics. As the first casebook in this field, the book is
designed to both describe and analyze a wide variety of topics covered
within the rubric of assisted reproductive technologies. Beginning with
artificial insemination, the book tracks each advance in reproductive
medicine - from in vitro fertilization to prenatal genetic testing to
human reproductive cloning - to display the full panoply of existing and
potential resources available to prospective parents. Armed with an
understanding of the workings, safety and efficacy of each reproductive
technique, the reader is encouraged to consider the social and moral
implications of producing offspring in ways that replace nature with
technology.
Man's ability to achieve and manipulate conception in the
laboratory raises unique concerns that are simply not attendant to
natural conception. Questions of parentage arise when a child is
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conceived using donated sperm or egg, or gestated by a woman paid for
her services. Questions of disposition arise when divorcing couples
disagree over the future of frozen embryos, or when a spouse dies
leaving gametes or embryos in storage for future use. Finally,
questions of public policy arise when researchers discover that human
embryos contain stem cells that could lead to medical cures and
therapies for countless patients, but the research itself presents a moral
dilemma for many. These and other topics are explored through a
combination of cases, statutes, policy statements, academic and
scientific commentary, organized with the goal of instructing and
inspiring the reader.
BRAVE NEW BABIES
Reviewed by: Lori Andrews"
Law professor George Annas once proposed that the entire last
semester of law school should be made up of health law courses.' He
said that health law is applied law - like physics is applied math - and
that it provides a way to review the entire law school curriculum.
2
Professor Judith Daar's new casebook, Reproductive
Technologies and the Law, 3 shows the merit in the Annas proposal. By
focusing on reproductive technologies, Daar presents a fascinating
application of myriad areas of law: from constitutional law to tort law,
from disability law to insurance law, from family law to probate law,
from human research law to international law. She also helps the
reader undertake a reasoned legal analysis of the implications of living
in a society where there are volatile disputes over the legal, social, and
moral status of the human embryo.
The reviewer of a casebook is in a unique position because she
reads, all at once, an entire volume that students generally read over the
course of a semester. Such a thorough reading can reveal problems in a
casebook, such as repetition, or unevenness in spots where it is clear
the author personally knows less about a particular topic and thus is
giving it short shrift. Daar's book, though, is engaging and thorough
throughout. I read it as one would read a novel and, indeed, it has some
of the characteristics of good fiction. It relates situations of desperation
1 George J. Annas, Health Law at the Turn of the Century: From White Dwarf to Red
Giant, 21 CONN. L. REV. 551, 553-4 (1989).2 id.
3 See generally JUDITH DAAR, REPRODUCTIVE TECHNOLOGIES AND THE LAW (2006).
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as people try to achieve their lifelong desire of becoming parents. It
provides a view of the culture as the reader contemplates practices such
as paying egg or sperm donors who have favored traits like physical
attractiveness, athletic ability, and high SAT scores. 4  The book
addresses the ethical implication of a biotechnology revolution that
allows people to treat human embryos and even children as a source of
medical treatments, such as when parents conceive a "savior sibling" -
a child who will donate bone marrow or other tissue to an existing ill
child.5 Profound social and economic issues are described- from the
concerns about racial disparity in fertility treatment 6 to concerns about
a practitioner in India who has perfected the practice of fatally snapping
the spinal cords of infant girls for families who cannot afford the high
tech approach to sex selection before birth.7
The legal conflicts at the heart of the casebook are intensely
personal. They reflect the moral aspirations and judgments not only of
the litigants but also of the judges and lawmakers. As a way of
reinforcing that point, Daar does something remarkable in the casebook
genre. She includes photographs of the people we have heard about
and read about for years. Thus we get a chance to view a grown-up
Louise Brown (the world's first "test tube baby") and her parents. 8 But
we also get to see Justice Oliver Wendell Holmes 9 in the context of the
Buck v. Bell1° decision, Harry Blackmun11 in the context of Roe v.
Wade, 12 and Justice Sandra Day O'Connor 13 in the discussion of
Planned Parenthood v. Casey.14 Daar also provides profiles of sperm
and egg donors who are selling their gametes, 15 and she gives
compelling information about what happened to some of the families
after they won or lost a landmark case. 16
4 See id. at 224-25.
' Id. at 329-330.
6 Id. at 197 (excerpting Dorothy E. Roberts, Race and the New Reproduction, 47
HASTINGS L. J. 935 (1996)).
7 DAAR, supra note 3, at 322 (reprinting Mary Carmichael, No Girls Please,
NEWSWEEK, Jan. 26, 2004, at 50.
8 DAAR, supra note 3, at 38.
9 Id. at 97.
10 274 U.S. 200, 47 S.Ct. 584 (1927).
11 DAAR, supra note 3, at 118.
12 410 U.S. 113, 93 S.Ct. 705 (1973).
13 DAAR, supra note 3, at 130.
14 505 U.S. 833, 112 S.Ct. 2791 (1992).
15 DAAR, supra note 3, at 201-204.
16 See, e.g., id. at 513-14 (updating the reader about the Lesbian couple in Adoption of
Tammy, 619 N.E.2d 315 (1993)).
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Also like a novel, Daar gives us occasional reprieves from the
serious, emotional context of many of the cases. At key points, the
casebook includes cartoons, such as a young girl telling her friend, "I
told my parents that if grades were so important they should have paid
for a smarter egg donor."' 17 Or a wife telling her husband, as he opens
the freezer, "[d]on't knock over the frozen embryos."' 8
Even some of the decisions themselves involve a dark humor.
You can always count on Judge Kozinski of the Ninth Circuit for a
clever or shocking analysis. In his dissent in a case about whether
prisoners have a reproductive liberty right to ship their sperm to their
wives for insemination, Kozinski opines, "[t]hat the package contains
semen, rather than a book or an ashtray or some other such object,
would seem to make no rational difference from the prison's point of
view. ... Nor, I would think, does the prison have a legitimate interest in
what the recipient does with the package. Whether it is used to
inseminate Mrs. Gerber, to clone Gerber or as a paperweight has no
conceivable effect on the safe and efficient operation of the California
prison system."' 
9
Daar puts the reader in the hot seat with a series of interesting
hypotheticals. In one, she asks you to assume that you have just been
elected to the state legislature. 0  A constituent whose daughter is
considering donating her eggs is worried the daughter will be harmed in
the process and wants you to introduce a bill banning egg donation.
Would you do it?
21
In another hypothetical, Daar asks you to imagine that you are a
physician practicing assisted reproductive technology. 22  An HIV-
seropositive gay couple who registered with the state as civil partners
want to create a child. The sister of one of the men will carry an
embryo created with her egg and the other man's sperm. Would you do
it? If not, why not? And, asks Daar, "[w]ould you give the same
answer to Brian and Rochelle, a married couple who are both carriers
of the recessive Tay-Sachs gene, meaning that...their offspring face a
25% chance of... suffering an early and painful death?, 23
17 DAAR, supra note 3, DAAR, supra note 3, at 250.
18Id. at 614.
19 Id. at 179. Gerber v. Hickman, 291 F.3rd 617 (2002).
20 Id. at 229.
21 Id.
22 DAAR, supra note 3, at 274.
23 id.
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As someone who has co-written a casebook,24 I know firsthand
how much work is involved and how many hundreds, if not thousands,
of choices are made in the process. 25 Which topics should go first?
How do you discuss cases that touch on multiple topics? How much
information about science and medicine is necessary for the reader to
be able to understand the key issues in the field? What types of
questions will stimulate the best class discussion? And, will anyone
really read the additional cases and law review articles cited in the
Notes sections?
As might be expected with any 880-page volume, there are a
few areas in which I have minor quibbles. For example, I would have
preferred a separate section on malpractice law, rather than having the
issues spread out, unevenly, through the book. Along those lines, it
would have been useful to have a discussion of the Stiver v. Parker
26
case, in which the Sixth Circuit held that the lawyers, doctors, and
psychologists in infertility settings have particularly high duties,
saying, "[t]his special relationship gives rise to affirmative duties to act
on the part of the surrogacy broker and program participants in order to
reduce the risk of harm to the child and to the surrogate mother and the
contracting father."
' 27
But my quibbles pale in comparison to the massive strengths of
the book. Besides, where else would I have learned that there is a
History of Contraception Museum near Toronto with a "display of over
600 different IUDs, sponges, condoms and other contraceptive
devices"? 28 Or that "[f]or the price of one I.V.F. cycle in the U.S.A.
the patient can come to South Africa, have the treatment done here in
Cape Town and have a lovely holiday at the same time and still take
some cash home.
' 29
While reproductive technologies may seem like a narrow niche
for a casebook, the legal system is constantly dealing with these cases.
24 LORI B. ANDREWS ET AL., GENETICS: ETHICS, LAW AND POLICY (West Publishing,
2006).
25 The fact that Daar was able to complete a casebook single-handedly is remarkable.
It is also a testament to the fact that Daar has been closely involved with the
reproductive technology field since the beginning. Her articles on whether and how
techniques such as in vitro fertilization and embryo research should be regulated are
classics in the field.
26 Stiver v. Parker, 975 F.2d 261 (6th Cir. 1992).
27 Id. at 270.
28 DAAR, supra note 3, at 110.
29 Id. at 189 (quoting Felicia R. Lee, Fertility Clinics Overseas Draw More From
U.S., NEW YORK TIMES, Jan. 25, 2005, at A1).
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Daar provides major excerpts from 232 cases. The decisions in this
area cast long shadows over family law, constitutional law, and human
research law more generally.
Just as the 1960's brought sex without procreation, now we
have technologies like in vitro fertilization that allow procreation
without sex. Assisted reproductive technologies, while helping couples
who might not otherwise be able to become parents, have created a
series of legal tangles. Some of the legal questions include:
" Parentage: Who should be considered the legal parents of any
resulting children?
" Excess Frozen Embryos: What should be done with excess
embryos created through in vitro fertilization in the event of
divorce, disagreement, or death?
" Posthumous Reproduction: Should a wife, girlfriend, or parent
be able to take sperm from dead men or men in comas to create
children?
" Preimplantation Diagnosis and Embryo Research: How do state
and federal laws influence what clinics do with embryos?
The assisted reproductive technology industry, with annual
revenues of nearly $7 billion, 30 is growing to serve an estimated 1 of 6
couples who are infertile. 31 A big area of concern for infertile couples
is whether their insurance will cover any of the costs they may incur as
they seek assistance. Currently, only 15 states require some sort of
insurance coverage for infertility treatments.32 If insurance does not
cover the treatment, couples take out second mortgages on their homes
and take on additional jobs to be able to pay for reproductive
technologies, yet not all are helped. 33 Seventy-five percent of in vitro
30 Deborah Hope, I Forgot to Buy a Baby, THE AUSTRALIAN, May 4, 2006, available
at http://www.theaustralian.news.com.au/story/0,20867,18338276-28737,OO.html.
31 Dolores Kong, What Price Pregnancy? THE BOSTON GLOBE, August 4, 1996, at
A35.
32 They are Arkansas, California, Connecticut, Hawaii, Illinois, Louisiana, Maryland,
Massachusetts, Montana, New Jersey, New York, Ohio, Rhode Island, Texas, and
West Virginia, available at
http://www.resolve.org/site/PageServer?pagename=fmed-mcpr20050707.
33 Regarding the in vitro statistics, the CDC report has success rates for IVF broken
into two categories: IVF without intracytoplasmic sperm injection (ICSI) and IVF
with ICSI. Success rates for the former is 34.0%, and for the latter are 31.9%. See
Centers for Disease Control and Prevention, 2002 Assisted Reproductive Technology
Success Rates: National Summary and Fertility Clinic Reports 38 (2004), available at
http://www.cdc.gov/ART/ART02/PDF/ART2002.pdf
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fertilization (IVF) cycles do not lead to a live birth.34 Despite these
difficulties, over 100,000 children are born yearly in the United States
through assisted reproductive technologies. 5 Contrast these numbers
with the number of healthy infants available for adoption - only about
30,000.36 One of the most striking things about this comparison is that
every state has an elaborate regulatory mechanism in place for adoption
while only a few states have enacted legislation to comprehensively
address assisted reproductive technologies. 37
Rather than regulations addressing the safety of reproductive
technologies or the informed consent of participants, most states with
laws in this area focus on paternity. In over half the states, the husband
of a consenting recipient of donor sperm is the father of the resulting
child.38 Currently, only a handful of states specifically address
parentage in egg donation. 39  Each of these statutes irrebuttably
presumes that a child resulting from egg donation is the child of the
couple who consented to receive the donated egg.40 Yet, in many other
states, the egg recipient in these states would have a strong claim to the
resulting child as well. The law generally recognizes the woman who
41gives birth as the legal mother, so the woman who gestates an
embryo created with a donor egg will be presumed to be the mother. In
states without an egg donation statute, there is nonetheless a small
chance that the donor of an unfertilized or fertilized egg would be able
to sue to claim parental rights to the resulting child. This might
happen, for example, if an Ivy League undergrad in a state without a
statute were paid $100,000 for an egg, but the procedure of egg
removal was negligent and left her infertile.
About half the states have adopted statutes regulating surrogate
parenting, but few adequately address issues of legal parenthood.
Michigan and Washington, for example, decide issues of custody based
14 See id.
35 At least 60,000 infants are born each year as a result of AID and 1,000 as a result of
surrogates. See ISLAT Working Group, ART into Science: Regulation of Fertility
Techniques, 281 Science 651 (1998). In addition, 48,756 infants were born as a result
of ART cycles carried out in 2003, the last year for which statistics are available. See
Centers for Disease Control and Prevention, 2003 Assisted Reproductive Technology
Success Rates: National Summary and Fertility Clinic Reports 13 (2006), available at
http://www.cdc.gov/ART/ART2003/PDF/ART2003.pdf.
36 NATIONAL COUNCIL FOR ADOPTION, HOTLINE INFORMATION PACKET 1 (1997).
37 DAAR, supra note 3, at 691-92.
38 See, e.g., 750 ILCS 40/2 to 40/3.
39 See, e.g., FLA. STAT. ANN. § 742.12.40 id.
41 See, e.g., 750 ILCS 45/4.
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on an evaluation of each individual case and a determination of what is
in the best interest of the child.42 Other states differ in whether they
presume that the contracting couple is the legal parents, that the
surrogate and her husband are the legal parents,43 or that the legal
parents are the surrogate and her husband unless the child is the genetic
offspring of the contracting couple. 44
And, what of the widow or widower who wants to procreate
after their better half has died? According to a survey of fertility
clinics by researchers at the University of Pennsylvania, there have
been at least 82 requests made by wives, girlfriends, or parents for post-
mortem sperm procurement from deceased individuals who ranged in
age from the early 20s to late 30s, two who were minors and one 60-
45year-old man. In the majority of cases for which data is available, a
physician alone made the decision about whether to honor the
request. 4
6
Another set of legal issues arises when couples try to decide the
fate of any excess frozen embryos they may have created. As of 2002,
there were 396,526 frozen embryos in the United States. 47 According
to one state legislator, the future of over 10% of them is in dispute.-4S
Since so many infertile couples must make a decision about
what to do with any excess embryos, the option of whether to donate
them for research purposes is something many couples will face.
Currently there has been a tremendous amount of focus on embryonic
stem cell research. In fact, President George W. Bush decided that
federal research funds may be used only for stem cell research on the
approximately 60 existing cell lines (so that no additional embryos
would be terminated). 4 9 But this leaves the private sector free to use
excess embryos from IVF clinics for research purposes.
42 See MICH. COMP. LAWS ANN. § 722.861; WASH. REV. CODE ANN. § 26.26.260.
43 See, e.g., N.D. CENT. CODE § 14-18-05.
44 750 ILCS 45/6(i).
45 Susan M. Kerr et al., Post Mortem Sperm Procurement, 157 J. UROLOGY 2154,
2155 (1997).
4 6 Id. at 2156.
4' David I. Hoffman et al., Cryopreserved Embryos in the United States and Their
Availability for Research, 79 FERTILITY & STERILITY 1063, 1066 (2003).
48 See LORI B. ANDREWS, THE CLONE AGE: ADVENTURES IN THE NEW WORLD OF
REPRODUCTIVE TECHNOLOGY at 62 (Henry Holt 2000) (providing further information
on embryo disputes).
49 "Remarks by President George W. Bush on Stem Cell Research, August 9, 2001,"
ANDREWS, supra note 24, at 173-175 (West Publishing, 2006).
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The states, as well as the federal government, play a role in
regulating research on embryos and fetuses. Some states have chosen
to ban embryo research entirely. 50 Others have enacted legislation to
specifically allow embryo stem cell research, and even so-called
therapeutic cloning.5 1  There is also considerable state legislation
affecting the commercialization of embryonic tissue.5 2 Certain states
include within their abortion laws or embryo and fetal research laws
bans on payment.53 Other states have adopted versions of the Uniform
Anatomical Gift Act, the law governing donation of tissue and organs
from a deceased individual for transplantation or treatment.
54
Another way infertile couples may some day be able to create
children is through cloning. The U.S. Congress is considering several
bills55 to ban the creation of children through cloning and it remains to
be seen whether such a ban will also include the creation of cloned
embryos solely for research purposes. However, at least thirteen states
have already moved ahead to prohibit human reproductive cloning. 
56
As technology evolves, parents-to-be will have even more
control over the traits of their offspring. In a Louis Harris poll
sponsored by the March of Dimes, 42% of potential parents surveyed
50 See, e.g., Fla.Stat. Ann. § 390.0111(6).
5' The states include California, CAL. HEALTH & SAFETY CODE § 125300 (West
2006); Massachusetts, MASS. ANN. LAWS ch. 11 IL, § 3 (West 2005); and New
Jersey, N.J. STAT. ANN. § 26:2Z-2 (West 2006).
52 Lori B. Andrews, "State Regulation of Embryo Stem Cell Research," in NATIONAL
BIOETHICS ADVISORY COMMISSION, ETHICAL ISSUES IN HUMAN STEM CELL
RESEARCH:
COMMISSIONED PAPERS, A-8 to A-9 (2000).
53 id.
54 See id.
'5 For example, proposed bills to ban reproductive cloning included: Human Cloning
Prohibition Act of 2005, S. 658, 10 9th Congress (2005); Human Cloning Prohibition
Act of 2005, H.R. 1357, 10 9th Cong. (2005); Human Cloning Ban Act of 2005, H.R.
3932, 10 9th Cong. (2005); Human Cloning Ban Act of 2005, H.R. 1520, 1 0 9 th Cong.
(2005).
56 These states include Arkansas, ARK. CODE ANN. § 20-16-1002 (Michie 2005);
California, CAL. HEALTH & SAFETY CODE § 24185 (West 2006); Connecticut, CONN.
GEN. STAT. § 19a-32d (2006); Indiana, IND. CODE ANN. § 35-46-5-2 (Michie 2006);
Iowa, IOWA CODE § 707B.2 (2006); Maryland, MD. ANN. CODE art. 83A, § 5-2B-13
(2006) (effective July 1, 2006); Massachusetts, MASS. ANN. LAWS ch. 11 IL, § 8
(West 2005); Michigan, MICH. COMP. LAWS ANN. § 750.430a (West 2006); New
Jersey, N.J. STAT. ANN. § 2C:l lA-I (West 2006); North Dakota, N.D. CENT. CODE §
12.1-39-02 (2005); Rhode Island, R.I. GEN. LAWS § 23-16.4-2 (2006); South Dakota,
S.D. CODIFIED LAWS § 34-14-27 (Michie 2005); and Virginia, VA. CODE ANN. §
32.1-162.22 (West 2005).
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said they would use genetic engineering on their children to make them
smarter; 43%, to upgrade them physically.57 Another survey found that
over a third of people wanted to tweak their children genetically to
make sure they had an appropriate sexual orientation. 58
The very boundaries of what is human could be changed by
reproductive and genetic technologies. Yet hardly anyone in the public
or the legislatures is paying attention. The designing of children is
occurring subtly, as a result of individual choices through an open
market. How are we, as a society going to judge such desires? Should
certain genetic manipulations be allowed and others not? Should
parents be able to buy height-enhancing genes for their embryos? Will
that be viewed more like cheating in sports or more like signing your
child up for private tennis lessons? Is giving a child a gene protective
against a deadly disease appropriate but manipulating genes for
cosmetic purposes not? Should the government intervene or should
couples be free from any intrusion in this type of decision-making?
These are the next generation of legal questions that infertility clinics
will face.
Daar's book comes at a crucial time. The law students of today
are the ones who are going to undertake the legal cases and write the
laws that address the frontier questions in the biotechnology realm:
Will we soon live among cloned human beings? Should parents be
permitted to give their infants genes for traits that humans never had
before, like the running speed of a cheetah? And if the designer babies
did not turn out the way the parents had planned, should lemon laws for
children allow them to get their money back?
With questions such as these, the wisdom of Solomon might be
needed once again. And Judith Daar's casebook can help this
generation of lawyers attain that wisdom.
57 See ANDREWS, supra note 48, at 143..
58 Public Opinion Survey Sponsored by Harpers Magazine (Nov. 1997) (on file with
author).
1364 [VOL.9.3:1355
